We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+0.57%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$234M
AUM Growth
-$93.7M
Cap. Flow
-$86.8M
Cap. Flow %
-37.11%
Top 10 Hldgs %
27.68%
Holding
338
New
19
Increased
53
Reduced
178
Closed
87

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$3.29M
2
WST icon
West Pharmaceutical
WST
+$2.66M
3
AVGO icon
Broadcom
AVGO
+$2.25M
4
AXON
Axon Enterprise
AXON
+$2.12M
5
NKE icon
Nike
NKE
+$2.06M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.16M
2
UTHR icon
United Therapeutics
UTHR
+$4.06M
3
RBA icon
RB Global
RBA
+$3.88M
4
TTC icon
Toro Company
TTC
+$3.77M
5
SJM icon
J.M. Smucker
SJM
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.08%
2 Consumer Staples 21.87%
3 Technology 13.57%
4 Financials 11.99%
5 Communication Services 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSLR icon
26
First Solar
FSLR
$22B
$2.95M 1.26%
23,330
+8,436
+57% +$1.32M
AVGO icon
27
Broadcom
AVGO
$1.7T
$2.94M 1.26%
17,548
+10,614
+153% +$2.25M
DKS icon
28
Dick's Sporting Goods
DKS
$12.4B
$2.81M 1.2%
13,918
-6,340
-31% -$1.42M
COR icon
29
Cencora
COR
$63.2B
$2.72M 1.16%
9,783
-13,715
-58% -$3.45M
NTNX icon
30
Nutanix
NTNX
$18.4B
$2.62M 1.12%
37,461
+4,970
+15% +$344K
AXON
31
Axon Enterprise
AXON
$41.9B
$2.61M 1.12%
4,969
+3,628
+271% +$2.12M
FTNT icon
32
Fortinet
FTNT
$115B
$2.56M 1.09%
26,560
-6,085
-19% -$617K
HDB icon
33
HDFC Bank
HDB
$119B
$2.5M 1.07%
75,302
+6,480
+9% +$198K
NBIX icon
34
Neurocrine Biosciences
NBIX
$15.8B
$2.44M 1.04%
22,012
-9,256
-30% -$1.17M
SRPT icon
35
Sarepta Therapeutics
SRPT
$2.38B
$2.41M 1.03%
37,808
+8,886
+31% +$935K
AMT icon
36
American Tower
AMT
$81.9B
$2.38M 1.02%
10,947
+8,931
+443% +$1.75M
HUM icon
37
Humana
HUM
$48.2B
$2.37M 1.01%
8,966
-6,443
-42% -$1.74M
PGR icon
38
Progressive
PGR
$127B
$2.19M 0.94%
7,754
-5,385
-41% -$1.41M
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.14T
$2.12M 0.9%
13,684
+2,264
+20% +$411K
JNJ icon
40
Johnson & Johnson
JNJ
$663B
$2.02M 0.86%
12,201
-20,517
-63% -$3.21M
KR icon
41
Kroger
KR
$35.9B
$2.01M 0.86%
29,750
-26,543
-47% -$1.68M
NEM icon
42
Newmont
NEM
$135B
$1.98M 0.85%
41,084
-14,590
-26% -$640K
UTHR icon
43
United Therapeutics
UTHR
$20.9B
$1.97M 0.84%
6,388
-11,834
-65% -$4.06M
NKE icon
44
Nike
NKE
$57B
$1.86M 0.79%
29,282
+27,929
+2,064% +$2.06M
FANG icon
45
Diamondback Energy
FANG
$55.8B
$1.81M 0.77%
11,322
+7,499
+196% +$1.21M
ED icon
46
Consolidated Edison
ED
$39.7B
$1.77M 0.76%
16,023
+14,267
+812% +$1.4M
SNAP icon
47
Snap
SNAP
$9.25B
$1.76M 0.75%
201,729
+137,078
+212% +$1.43M
DLTR icon
48
Dollar Tree
DLTR
$24.7B
$1.74M 0.74%
23,150
+17,739
+328% +$1.27M
PFE icon
49
Pfizer
PFE
$162B
$1.69M 0.72%
66,755
-158,987
-70% -$4.16M
CHRW icon
50
C.H. Robinson
CHRW
$17.3B
$1.65M 0.71%
16,115
+11,710
+266% +$1.18M

Similar funds

TOBAM's Q1 2025 Portfolio in Review

As of Q1 2025, TOBAM held 338 positions worth $234M, down 29% from $328M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TOBAM withdrew a net $86.8M in Q1 2025, closing 87 positions and reducing 178 holdings. Its most notable exit was Toro Company, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 29% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Expeditors International worth $1.14M.

  • TOBAM's largest Q1 2025 buy was Expeditors International: 9,454 shares worth $1.14M.
  • TOBAM added most to Electronic Arts in Q1 2025, an estimated $3.29M increase.
  • TOBAM's biggest Q1 2025 reduction was Pfizer, cutting an estimated $4.16M.
  • TOBAM fully exited Toro Company in Q1 2025, selling an estimated $3.77M.
  • TOBAM's ten largest holdings make up 28% of its $234M portfolio in Q1 2025.
  • TOBAM opened 19 new positions and closed 87 in Q1 2025.
  • TOBAM's portfolio value fell 29% quarter-over-quarter to $234M.

Based on TOBAM's 13F filing for Q1 2025, filed 16 Apr 2025.